Pharma stocks drop as Trump nominates Robert F Kennedy Jr for health secretary

dailymail.co.uk — November 15, 2024 at 11:01 PM UTC

Shares of major pharmaceutical companies fell sharply after Donald Trump nominated Robert F. Kennedy Jr. as the U.S. health secretary. Kennedy is known for his skepticism about vaccines and has made controversial statements regarding public health policies. AstraZeneca and GSK saw declines of 3.1% and 3.9%, respectively, while other companies like Croda International and Sanofi also experienced drops. U.S. firms Pfizer and Moderna fell 4.4% and 8.9% following the announcement. Kennedy's past comments on vaccines and public health measures have raised concerns among investors, contributing to uncertainty in the pharmaceutical sector.

With a significance score of 2.9, this news ranks in the top 24% of today's 17973 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 9000 minimalists.

Timeline:

[2.1]

Stephen Colbert mocks Dr. Oz's cabinet appointment in comedic segment (newsweek.com)

113d 16h